Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

No Thumbnail Available
File version
Author(s)
Brownlee, Wallace
Bourdette, Dennis
Broadley, Simon
Killestein, Joep
Ciccarelli, Olga
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2020
Size
File type(s)
Location
License
Abstract

The emergence of novel coronavirus 2019 (COVID-19)1 and the subsequent pandemic present a unique challenge to neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).

National professional bodies (e.g., Italian Society of Neurology and Association of British Neurologists) and patient organizations (e.g., National MS Society, MS International Federation, UK MS Society, and MS Australia) have responded rapidly by issuing guidelines for the COVID-19 pandemic, primarily focused on MS disease-modifying therapies (DMTs). In this commentary, we highlight the implications of COVID-19 for people with MS and related disorders, including the risk of respiratory infections, general health advice, and recommendations (from consensus-based guidelines) for immunotherapies, relapse management, and service delivery during the COVID-19 pandemic.

Journal Title

Neurology

Conference Title
Book Title
Edition
Volume

94

Issue

22

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

Self-archiving of the author-manuscript version is not yet supported by this journal. Please refer to the journal link for access to the definitive, published version or contact the author[s] for more information.

Item Access Status
Note
Access the data
Related item(s)
Subject

Clinical sciences

Neurosciences

Cognitive and computational psychology

Science & Technology

Life Sciences & Biomedicine

Clinical Neurology

Neurology

Persistent link to this record
Citation

Brownlee, W; Bourdette, D; Broadley, S; Killestein, J; Ciccarelli, O, Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic, Neurology, 2020, 94 (22), pp. 949-952

Collections